Expression of Galectin-3, nm-23, and Cyclooxygenase-2 Could Potentially Discriminate Between Benign and Malignant Pheochromocytoma
Open Access
- 1 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 135 (3), 454-460
- https://doi.org/10.1309/ajcpi8ajluz3czln
Abstract
Currently, the only reliable indicator of malignancy in pheochromocytoma is the presence of distant metastasis or extensive local invasion; predicting behavior of pheochromocytoma remains challenging. We aimed to correlate the behavior of pheochromocytoma with its expression of nm-23, cyclooxygenase (COX)-2, and galectin-3 (genes used to predict the course of some neoplastic diseases), evaluated immunohistochemically in 55 paraffin blocks of formalin-fixed pheochromocytoma specimens with confirmed behavior. In 3 (7%) of 44 benign and 7 (64%) of 11 malignant pheochromocytomas, there was negative nm-23 expression (P = .000). COX-2 immunoreactivity was positive in 10 (23%) of benign and 9 (82%) of malignant tumors (P = .000). Galectin-3 was expressed in 5 (11%) of benign and 9 (82%) of malignant pheochromocytomas (P = .000). Negative nm-23, along with positive COX-2 or galectin-3, predicted malignancy with 100% specificity. Dual negativity for galectin-3 and COX-2, along with nm-23 positivity, indicated benign behavior with 100% sensitivity. In early pheochromocytoma, evaluation of nm-23, galectin-3, and COX-2 expression could predict the outcome. Larger studies seem necessary to confirm the potential practical value of our findings.Keywords
This publication has 27 references indexed in Scilit:
- The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II☆European Journal of Cardio-Thoracic Surgery, 2007
- NSAIDs and breast cancer recurrence in a prospective cohort studyCancer Causes & Control, 2007
- Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: Implications in the extracellular functions of the lectinExperimental Cell Research, 2007
- Cyclooxygenase‐2 expression in medullary thyroid carcinomaHead & Neck, 2007
- Distinct Expression of Galectin-3 in PheochromocytomasAnnals of the New York Academy of Sciences, 2006
- Identification of Functional Genetic Variants in Cyclooxygenase-2 and Their Association With Risk of Esophageal CancerGastroenterology, 2005
- Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growthLaboratory Investigation, 2005
- Expression profile of genes associated with antimetastatic gene:nm23-Mediated metastasis inhibition in breast carcinoma cellsInternational Journal of Cancer, 2003
- Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant NeoplasmsThe American Journal of Surgical Pathology, 2002
- Expression of Metastasis-Associated Genesh-mts1(S100A4) andnm23in Carcinoma of Breast Is Related to Disease ProgressionDNA and Cell Biology, 1998